Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Moderna (MRNA)
NASDAQ:MRNA
Moderna (MRNA) Stock Price & Analysis
13,715 Followers
MRNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$115.03 - $217.25
Previous Close$126.24
Volume3.64M
Average Volume (3M)3.45M
Market Cap
$48.12B
Enterprise Value$40.13B
Total Cash (Recent Filing)$8.92B
Total Debt (Recent Filing)$927.00M
Price to Earnings (P/E)10.9
Beta1.16
Next Earnings
Aug 09, 2023EPS Estimate
-$3.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)11.59
Shares Outstanding381,209,341
10 Day Avg. Volume3,674,397
30 Day Avg. Volume3,454,828
Standard Deviation0.28
R-Squared0.11
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)2.68
Price to Sales (P/S)25.84
Price to Cash Flow (P/CF)-10.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.16
Enterprise Value/Gross Profit2.90
Enterprise Value/Ebitda11.28
Forecast
1Y Price Target
$229.63Price Target Upside81.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Moderna News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MRNA FAQ
What was Moderna’s price range in the past 12 months?
Moderna lowest stock price was $115.03 and its highest was $217.25 in the past 12 months.
What is Moderna’s market cap?
Currently, no data Available
When is Moderna’s upcoming earnings report date?
Moderna’s upcoming earnings report date is Aug 09, 2023 which is in 73 days.
How were Moderna’s earnings last quarter?
Moderna released its earnings results on May 04, 2023. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of -$1.747 by $1.937.
Is Moderna overvalued?
According to Wall Street analysts Moderna’s price is currently Undervalued.
Does Moderna pay dividends?
Moderna does not currently pay dividends.
What is Moderna’s EPS estimate?
Moderna’s EPS estimate is -$3.97.
How many shares outstanding does Moderna have?
Moderna has 381,209,350 shares outstanding.
What happened to Moderna’s price movement after its last earnings report?
Moderna reported an EPS of $0.19 in its last earnings report, beating expectations of -$1.747. Following the earnings report the stock price went up 3.22%.
Which hedge fund is a major shareholder of Moderna?
Among the largest hedge funds holding Moderna’s share is Flagship Pioneering Inc.. It holds Moderna’s shares valued at 2B.
---
Moderna Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$229.63 (81.90% Upside)
$229.63 (81.90% Upside)
Blogger Sentiment
Bullish
MRNA Sentiment 89%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 298.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.03%
12-Months-Change
Fundamentals
Return on Equity
26.62%
Trailing 12-Months
Asset Growth
-12.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Moderna
Incorporated in 2010, Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on messenger ribonucleic acid (mRNA) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
---
Top 5 ETFs holding MRNA
Vanguard S&P 500 ETF
$1.18B
Invesco QQQ Trust
$639.39M
SPDR S&P 500 ETF Trust
$480.82M
SPDR S&P 500 ETF Trust CDI
$462.88M
iShares Core S&P 500 ETF
$369.92M
Up to five ETFs with an Outperform Smart Score that hold MRNA. The ETFs are listed according to market value of MRNA within the ETF
---
---